The DOI matches its Crossref record; 136 of the 137 references it cites were found in a registry or an index.
Prebiotics, immune function, infection and inflammation: a review of the evidence
Open accessAbstract
Beta2-1 fructans are carbohydrate molecules with prebiotic properties. Through resistance to digestion in the upper gastrointestinal tract, they reach the colon intact, where they selectively stimulate the growth and/or activity of beneficial members of the gut microbiota. Through this modification of the intestinal microbiota, and by additional mechanisms, beta2-1 fructans may have beneficial effects upon immune function, ability to combat infection, and inflammatory processes and conditions. In this paper, we have collated, summarised and evaluated studies investigating these areas. Twenty-one studies in laboratory animals suggest that some aspects of innate and adaptive immunity of the gut and the systemic immune systems are modified by beta2-1 fructans. In man, two studies in children and nine studies in adults indicate that the adaptive immune system may be modified by beta2-1 fructans. Thirteen studies in animal models of intestinal infections conclude a beneficial effect of beta2-1 fructans. Ten trials involving infants and children have mostly reported benefits on infectious outcomes; in fifteen adult trials, little effect was generally seen, although in specific situations, certain beta2-1 fructans may be beneficial. Ten studies in animal models show benefit of beta2-1 fructans with regard to intestinal inflammation. Human studies report some benefits regarding inflammatory bowel disease (four positive studies) and atopic dermatitis (one positive study), but findings in irritable bowel syndrome are inconsistent. Therefore, overall the results indicate that beta2-1 fructans are able to modulate some aspects of immune function, to improve the host's ability to respond successfully to certain intestinal infections, and to modify some inflammatory conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The microbiota composition and the related local intestinal metabolism undergoes significant changes in various disease states that are characterised by chronic inflammation, such as inflammatory bowel disease (823) , colorectal cancer and obesity (824,825) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [823]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
Gibson, G. R., & Roberfroid, M. B. (1995) · Journal of Nutrition · doi:10.1093/jn/125.6.1401 · Cited by 7,659
Dietary modulation of the human colonic microbiota: updating the concept of prebiotics
Gibson, G. R., Probert, H. M., Loo, J. V., Rastall, R. A., & Roberfroid, M. B. (2004) · Nutrition Research Reviews · doi:10.1079/nrr200479 · Cited by 2,539
Brown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409
Le Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301403200 · Cited by 1,651
Brown, G. D., & Gordon, S. (2001) · Nature · doi:10.1038/35092620 · Cited by 1,579
Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin
Gibson, G. R., Beatty, E. R., Wang, X., & Cummings, J. H. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90192-2 · Cited by 1,529
On the presence of Inulin and Oligofructose as natural ingredients in the western diet
Loo, J. V., Coussement, P., Leenheer, L. D., Hoebregs, H., & Smits, G. (1995) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408399509527714 · Cited by 837
Introducing inulin-type fructans
Roberfroid, M. B. (2005) · British Journal Of Nutrition · doi:10.1079/bjn20041350 · Cited by 816
The Bifidogenic Nature of Chicory Inulin and Its Hydrolysis Products
Roberfroid, M. B., Loo, J. V., & Gibson, G. R. (1998) · Journal of Nutrition · doi:10.1093/jn/128.1.11 · Cited by 781
Research works printed but not linked: 5
- Bunce, 1995, Protective effect of fructooligosaccharides (FOS) in prevention of mortality and morbidity from infectious E. coli, J Anim Sci, 71, 69
- Firmansyah, 2001, Improved humoral immune response to measles vaccine in infants recieving infant cereal with fructooligosaccharides, J Paediatr Gastroenterol Nutr, 31, A521
- 10.1079/BJN/2002541 · DOI
- Berg, 1985, Indigenous intestinal microflora and the host immune response, EOS J Immunol Immunopharmacol, 4, 161
- 10.1080/08035320510043637 · DOI
Cited by
Sorted by citations
Prebiotic effects: metabolic and health benefits
Roberfroid, M. B., Gibson, G. R., Hoyles, L., McCartney, A. L., Rastall, R. A., Rowland, I. R., Wolvers, D. A. W., Watzl, B., Szajewska, H., Stahl, B., et al. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510003363 · Cited by 2,170
Dietary factors and low-grade inflammation in relation to overweight and obesity
Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., Esposito, K., Jönsson, L. S., Kolb, H., Lansink, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511005460 · Cited by 1,098
Self-citationPreidis, G. A., & Versalovic, J. A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.072 · Cited by 494
Prebiotics from marine macroalgae for human and animal health applications
O’Sullivan, L., Murphy, B., McLoughlin, P., Duggan, P., Lawlor, P. G., Hughes, H., & Gardiner, G. E. (2010) · Marine Drugs · doi:10.3390/md8072038 · Cited by 421
Ageing of the human metaorganism: the microbial counterpart
Biagi, E., Candela, M., Fairweather‐Tait, S. J., Franceschi, C., & Brigidi, P. (2011) · AGE · doi:10.1007/s11357-011-9217-5 · Cited by 375
Metadata
- Authors
- Lomax, A. R., & Calder, P. C.
- Affiliations
- University of Southampton (GB)
- Corresponding author
- Lomax, Amy R.
- ORCID
- Calder, Philip C.
- Venue
- British Journal Of Nutrition
- Publisher
- Cambridge University Press (CUP)
- Published
- 2008-09-25
- Volume
- 101
- Issue
- 5
- Pages
- 633-658
- ISSN
- 0007-1145 (ISSN-L)
- 1475-2662
- OpenAlex
- W1991759182
- Cited by
- 257
- References
- 137
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 3 · 2023: 6 · 2022: 18 · 2021: 19 · 2020: 20 · 2019: 20 · 2018: 20 · 2017: 16 · 2016: 14 · 2015: 10 · 2014: 23 · 2013: 17 · 2012: 16
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal Of Nutrition (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- prebiotics, gut microbiota, immune function, innate immunity, adaptive immunity, intestinal infection, intestinal inflammation, inflammatory bowel disease, atopic dermatitis, irritable bowel syndrome, infants and children
- MeSH terms
- Adult, Aged, Animals, Child, Child, Preschool, Disease Models, Animal, Female, Fructans, Humans, Immune System, Infant, Infant, Newborn, Inflammation, Intestines, Lymphoid Tissue, Male, Middle Aged, Opportunistic Infections, Evidence-Based Medicine, Young Adult, Prebiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
